Oneness Biotech , Ltd. P/E Ratio

Oneness Biotech , Ltd. (4743.TWO) currently reports a P/E ratio of 352.58. That is above the Healthcare sector average of 70.94. Use the charts on this page to explore Oneness Biotech , Ltd.'s P/E ratio history and peer comparisons.

Oneness Biotech , Ltd.'s P/E ratio of 352.58 is higher than the Healthcare sector average of 70.94. That is roughly 397.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Oneness Biotech , Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At 352.58, 4743.TWO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 352.58, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for Oneness Biotech , Ltd., and consider following 4743.TWO for alerts when major investors trade the stock.

Oneness Biotech , Ltd. is classified in the Healthcare sector. On P/E ratio, it currently shows 352.58 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4743.TWO with unrelated industries.